PCBL Chemical Limited (PCBL)
Large CapChemicals stocks · Large cap · NSE
PCBL Chemical Limited manufactures carbon black, a key ingredient for the tyre and non-tyre industries, and operates a specialty chemicals business (Aquapharm) focusing on water solutions, home care, and oil & gas. The company is also diversifying into battery chemicals through its Nanovace platform.
One read, four checks
75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.
Weak fundamentals, management trust needs verification, price trend is neutral, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
low confidence · 0/0 claims checked
Timing lens: price trend and sector relative strength.
Rolling lens: recent quarterly delivery, not the latest single-result score.
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +17% YoY · PAT +65% YoY · margin expansion · +20% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹2,473 Cr | +17.0% | +19.7% |
| EBITDA | ₹396 Cr | +24.1% | +63.0% |
| Operating margin | 16.0% | +100 bps | +400 bps |
| PAT | ₹155 Cr | +64.9% | +287.5% |
| PAT margin | 6.3% | +182 bps | +433 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Where growth can come from, and what can break the case
Q4 FY26 Carbon Black Volumes Up YoY, But Margins Pressured by West Asia Conflict & Input Costs; Aquapharm Faces Headwinds.
The company navigated significant Q4 FY26 headwinds from the West Asia conflict, crude volatility, and logistics costs, impacting margins and Aquapharm's performance. However, management highlights clear recovery signals, including US tariff rationalization, India-EU FTA, customer restocking, and cost initiatives, projecting double-digit EBITDA growth for FY27.
Specialty Carbon Black
Specialty sales volumes grew by 26% YoY to 19,386 tons in Q4 FY26. Management is selectively increasing focus and resource reallocation in this segment.
Battery Chemicals (Nanovace)
Pilot plant at Palej is fully equipped and ready for commissioning within weeks. Engagement with large battery manufacturers is underway to validate product properties.
Export Market Expansion
India-EU FTA opens duty-free access to 1.8 million tons carbon black market. Recent U.S. tariff reduction restores cost advantage for Indian exports, seeing good traction from US customers.
Cost Reduction Initiatives
Program is progressing well, on track to unlock over INR 200-250 crores of savings over the next 4-6 quarters through yield improvement, throughput enhancement, and feedstock diversification.
Carbon Black Capacity
Added 90,000 tons of carbon black capacity (Brownfield expansion at Tamil Nadu), bringing total installed capacity to 880,000 tons per annum.
Superconductive Specialty Black Line
1,000 MTPA line at Palej, Gujarat, is mechanically ready for commissioning, but delayed due to gas shortage.
Specialty Black Line (Mudra)
20,000 tons line in Mudra is ready and will be commissioned in the next few weeks.
Aquapharm Capacity
Successfully expanded capacity from 130,000 tons to 167,000 tons during the year.
Industry Recovery Signals
Broad industry dynamics show clear signs of recovery; spreads appear to have found a floor, and exit quarter momentum has turned positive.
Favorable Trade Policies
Recent rationalization of U.S. tariffs restored a meaningful cost advantage for Indian exports. India-EU FTA opens duty-free access to a significant carbon black market.
Customer Inventory Restocking
Customers are shifting from just-in-time to a 'just-in-case' approach, building strategic inventory buffers, which is translating into incremental demand.
Indian Tyre Sector Growth
The Indian tyre sector in FY27 is poised for robust, high single-digit growth, supported by high vehicle usage and aging commercial vehicle fleet.
West Asia Conflict Impact
Escalation of West Asia conflict created significant disruptions, massive increases in logistics cost, cost of feedstock, and availability of ships.
Raw Material Price Volatility
Raw material prices (linked to crude) rose sharply; Brent started at $60, ended March at $100, and is hovering close to $120 per barrel.
Contractual Lag Effect
Formula-based contracts with tyre majors carry an inherent quarterly lag effect, meaning the full impact of cost pass-through will reflect in Q2 FY27.
Aquapharm Raw Material & Logistics
Aquapharm faced 25-30% rise in raw material prices (yellow phosphorus, acrylic acid, malic acid), increased lead times, and freight rates due to West Asia conflict.
Geopolitical Instability
Ongoing West Asia conflict continues to pose risks to global supply chains, logistics, and raw material costs, impacting profitability.
Crude Price Volatility
Raw material prices are directly linked to crude, and continued high volatility can exert significant pressure on margins.
Domestic Overcapacity
Surplus domestic capacity in the carbon black industry persisted through Q4 FY26, potentially limiting pricing power.
New Product Qualification
Battery chemicals (Nanovace) require a validation period of a few months post-commissioning before capacity ramp-up begins.
Management accountability
What management said, and what results must prove
Management accountability
What management said, and what results must prove
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is relevant for assessing overall growth and the impact of annual trends. QoQ is crucial for understanding sequential momentum, especially given the stated lag effect of cost pass-through in contracts and the expected recovery consolidation over the next 2-3 quarters.
Carbon Black Sales Volume (Q4 FY26)
Consolidated sales volume increased by 8% YoY to 161,865 MT. Domestic sales volume grew by 21% YoY to 105,055 tons, while international sales volume decreased by 10% to 56,800 tons.
Carbon Black Sales Volume (FY26)
Sales volume for carbon black decreased 4% YoY to 618,956 metric tons in FY26 (vs 596,262 metric tons in FY25).
Consolidated EBITDA (Q4 FY26)
Consolidated EBITDA were INR 248 crores.
Consolidated EBITDA (FY26)
Consolidated EBITDA for FY26 stood at INR 1,081 crores as against INR 1,384 crores in FY25.
FY27 Outlook & Growth
Confident of delivering double-digit EBITDA growth in FY27, fueled by volume momentum, leaner cost structure, and better pricing realization.
Capital Allocation
Maintaining capital discipline with investment priorities towards specialty carbon black, battery chemicals, and other value-added segments.
Aquapharm Profitability Target
Goal remains to reach INR 75 crores per quarter EBITDA run rate for Aquapharm over the next 2-3 quarters.
Long-Term EBITDA Guidance
The long-term fundamentals remain intact, and the INR 40 billion EBITDA guidance by 2030 remains on track.
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Carbon Black EBITDA per ton | Q4 FY26 EBITDA per ton not explicitly stated, but management noted it did not improve much QoQ. | Strong double-digit increase in EBITDA per ton for FY27, driven by pricing, product mix, and cost initiatives. |
| Aquapharm Quarterly EBITDA | INR 29 crores in Q4 FY26. | Achievement of INR 75 crores per quarter EBITDA run rate within the next 2-3 quarters. |
| Nanovace (Battery Chemicals) Progress | Pilot plant ready for commissioning; product validation with large battery manufacturers underway. | Successful product qualification and commencement of commercial volumes, expected in FY28. |
| Cost Savings Realization | Program progressing well. | Realization of INR 200-250 crores of savings over the next 4-6 quarters from yield, throughput, and feedstock diversification. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trend score and candlestick chart
53NeutralSMA20 -1.8% / mo · MACD −
Technical chart
PCBLdaily · 1Y · AUTO+11.6%Daily technical trend read
Bearish setupTrend is weak — long-term uptrend intact. RSI 48.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 falling (~1.8% over last month) — short-term momentum negative.
- RSI(14) at 48 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 26% off 52W high · 40% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Relative Strength & Trend Stage
- Price is 6.6% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +2.1%.
- Both 3-month and 6-month returns are positive.
Valuation & score drivers
U-Score 28 · OVERVALUED · pillar breakdown, sector model, fair-value anchor
Valuation & score drivers
U-Score 28 · OVERVALUED · pillar breakdown, sector model, fair-value anchor
Fundamental score breakdown
OVERVALUEDWhy this score?
Top U-Score contributors and drags from the latest stored fundamentals.
Positive drivers
- FCF yield is supportive at 7.2%.
- Cash flow contributes 10/10 to the score.
- Balance sheet contributes 5/15 to the score.
Main drags
- Fair-value margin of safety is negative at -953.9%.
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Valuation is weaker at 2/30; verify the latest quarterly trend.
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Score history
12 stored score snapshots. Latest stored move: +0 points.
Factor attribution
Modelled fair value
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Mixed Trust: Claim history is still being built. It ranks around the 23rd percentile of the scored universe and 13th percentile within Chemicals. Main check: financial discipline is weak at 18/100.
Mixed Trust Lite: Promoter pledge is zero. Key concern: 3 latest quarters had PAT decline worse than 25% YoY.
Usable, but needs evidence. Treat guidance with a margin of safety.
overall median 67 · Chemicals: 13th pctile, median 73 · Large: 13th pctile, median 73
76 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Mixed Trust · low confidenceRead Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust positives
- ▸Promoter pledge is zero.
- ▸Promoter holding increased 2%.
- ▸FCF yield is 7.2%.
- ▸8 years of positive FCF.
Trust risks
- ▸3 latest quarters had PAT decline worse than 25% YoY.
- ▸Debt/equity is 1.25.
- ▸ROCE is low at 7.8%.
- ▸ROE is low at 5.6%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Fundamentals
Valuation
- P/E
- 47.10
- P/B
- 3.11
- EV/EBITDA
- 11.62
- Market Cap
- 12473.00Cr
Profitability
- ROE
- 5.56%
- ROCE
- 7.75%
- ROA
- 2.29%
- Dividend Y
- 1.89%
Growth (CAGR)
- Revenue 5Y
- 25.00%
- EPS 5Y
- -7.00%
- Revenue 3Y
- 12.00%
- EPS 3Y
- -21.00%
Balance Sheet
- Debt/Equity
- 1.25
- Interest Coverage
- 2.78×
- Altman Z
- 2.73
- Book Value
- 102.00
Cash Flow
- FCF Yield
- 7.22%
- FCF Positive Y
- 8/5
- OCF
- 1576.00 Cr
- EPS TTM
- 6.64
Shareholding
- Promoter Hold
- 53.38%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 46%
Financial History
Updated 5/9/2026
Revenue
₹ CrNet Profit
₹ CrReturn on Equity
%Peers
Business-comparable names in Chemicals, ranked by similarity
Peers
Business-comparable names in Chemicals, ranked by similarity
Peers
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.